The Pharmaceutical Journal
Vol 271 No 7273 p612
1 November 2003

This page
Reprint
Photocopy

PDF* 120K

  Concordance
  Law and Ethics
  Out of hours
  Ask about medicines
  Ramadan
  Needle exchange
  Specials
  Ramipril
  Medication errors
  Preregistration exam
  The Charter
  The Profession

Letters to the Editor

Ramadan

Co-trimoxazole is restricted

From Mr C. Anton

I was concerned to see that the article (PJ, 10 November 2001, p691) mentioned in the news item about Ramadan (PJ, 25 October, p572) advocates that patients may wish to consider taking co-trimoxazole for upper respiratory tract infections because of its twice daily dosing schedule.

The Committee on Safety of Medicines recommends that, because of serious skin and haematological adverse effects, co-trimoxazole should only be used for Pneumocystis carinii pneumonia and acute exacerbations of chronic bronchitis when there is evidence of bacterial sensitivity.

Christopher Anton
Administrative Co-ordinator,
West Midlands Centre for Adverse Drug Reaction Reporting,
City Hospital,
Birmingham

Send your letter to The Editor

Previous Topic (Ask about medicines)
Next Topic (Needle exchange)